CLOV

CLOVER HEALTH INVESTMENTS, CORP.

Nasdaq· Hospital & Medical Service Plans· Inc. DE· CIK 0001801170 Traditional Finance

$4.56 −0.04 (−0.87%)

Oct 26 4:00 PM ET · prev $4.60

Market cap

$2.5B

Mid cap

Consensus

Buy

70% Buy or better · 10 analysts

Median target

$5.25

+15% · range $5.00–6.00

Next earnings

Nov 4

in 9 days

1 year

+19.7%

from $3.81 · Oct 27

30 days

+5.3%

from $4.33

52-week range

$1.70–5.41

−16% from high · low Apr 1

Avg volume 20D

4.16M

Oct 9 spike 10.55M

Short interest

🔒 Subscribers only

Insider net

−$8.3M

0 buyers · 8 sellers · since Apr 3

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read BEARISH 14 reports · 90 days

Balance 6 bearish · 1 bullish · 7 neutral oldest → newest, height = score

Avg score

·High conf. 6/14 ·Next Earnings date, Nov 4, 2026

Strongest BULLISH Clover Health announced that CMS awarded its PPO Medicare Advantage plans a 5-Star rating and its HMO plan a…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

S May 13 to May 18 2 days of insider sells: $574.8K by 2 insiders, avg $3.48
S Jun 11 to Jun 17 4 days of insider sells: $156.7K by 3 insiders, avg $4.78
S Jul 1 to Jul 20 6 days of insider sells: $2.5M by 5 insiders, avg $5.07
S Aug 10 to Aug 17 2 days of insider sells: $486.3K by 2 insiders, avg $4.61
S Sep 14 to Sep 17 4 days of insider sells: $1.6M by 4 insiders, avg $4.75
S Oct 1 to Oct 7 3 days of insider sells: $1.4M by 2 insiders, avg $4.20
R Oct 8 Clover Health announced that CMS awarded its PPO Medicare Advantage…
S Oct 15 to Oct 20 3 days of insider sells: $685.0K by 5 insiders, avg $4.67

Signal stack

Where each data set points today.

InsidersBEARISH

8 insiders sold $8.3M.
InstitutionsBULLISH

Q2 2026: 19 added (0 new), 11 trimmed or exited.
AnalystsBULLISH

7 of 10 rate it Buy or better. Every target is above the price.
TrendUPTREND

2% above its 50-day average.
SocialQUIET

No Reddit mentions this week. Last mention Oct 9.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
Nuveen, LLC	DOUBLED	6,291,699	$33.0M
D. E. Shaw & Co., Inc.	DOUBLED	1,965,493	$10.3M
GOLDMAN SACHS GROUP INC	TRIM	1,170,742	$6.1M
Point72 Asset Management, L.P.	DOUBLED	1,069,645	$5.6M
GROUP ONE TRADING LLC	ADD	747,239	$3.9M
IMC-Chicago, LLC	ADD	643,030	$3.4M
UBS Group AG	NEAR_EXIT	409,450	$2.1M
WELLS FARGO & COMPANY/MN	DOUBLED	395,057	$2.1M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

10 analysts

Buy 70% rate it Buy or better

Strong Buy2Buy5Hold3Sell0Strong Sell0

12-month targets · 4 analysts

$4.56 $5.00 $5.25 $6.00

Price is below the lowest target. Median implies +15%.Targets as of Oct 26, 2026.

Recent actions

Date	Firm	Action	Rating
Aug 6, 2026	UBS MAINTAIN	MAINTAIN	Neutral
Jul 21, 2026	Canaccord Genuity MAINTAIN	MAINTAIN	Buy
Jun 11, 2026	UBS MAINTAIN	MAINTAIN	Neutral
Jun 4, 2026	Canaccord Genuity MAINTAIN	MAINTAIN	Buy

Insider ledger

Form 4

bought · 0 insiders

$8.3M

sold · 8 insiders

Date	Insider	Type	Value
Oct 20, 2026	Soares Karen Chief Legal Officer	SELL	$89.8K
Oct 19, 2026	Reynoso Jamie L. CEO, Medicare Advantage	SELL	$17.9K
Oct 15, 2026	Reynoso Jamie L. CEO, Medicare Advantage	SELL	$85.5K
Oct 15, 2026	Wai Conrad CEO, Counterpart Health	SELL	$110.6K
Oct 15, 2026	Toy Andrew Chief Executive Officer	SELL	$291.0K
Oct 15, 2026	Soares Karen Chief Legal Officer	SELL	$68.7K
Oct 15, 2026	THORNTON JOSEPH CLAY Interim CFO	SELL	$21.5K
Oct 7, 2026	Reynoso Jamie L. CEO, Medicare Advantage	SELL	$9.3K

Earnings setup

Estimates

Nov 4

reports in 9 days

Revision history: 🔒 Fresh data, subscribers only

Period	EPS est.	Range	30D rev.	Revenue
Current Q	🔒 Fresh data, subscribers only
Next Q	🔒 Fresh data, subscribers only
Current FY	🔒 Fresh data, subscribers only
Next FY	🔒 Fresh data, subscribers only